John Paulson

John Paulson Has Had Better Days

Between a rock and a hard place.Also better weeks/months/years. Read more »

John Paulson Declares The U.S. Recovery Over

Doin' what he has to do.Not only is the noted patriot no longer making any money on the Great American Turnaround, he’s losing money! Lots of it last month, on all of the same things his other funds lost lots of money on. So it’s time for a change. In this case, a change to be more like all of his other funds. Read more »

Take it or leave it.At a sizeable discount, por favor. Read more »

John Paulson Really Needs Someone To Buy Shire ASAP

Knows what it feels like to be the Knicks.AbbVie’s decision that Shire without the tax inversion break really isn’t worth the $54 billion hasn’t just gotten Paul Singer’s lawyers busy: It also put the probably final nail in what had been a very promising year for old John Paulson. The non-merger, coupled with a judge’s annoyingly legalistic insistence on not just letting hedge funds have everything they want with regard to Fannie Mae and Freddie Mac, cost Paulson’s Advantage Fund 14% last month, giving him quite the hill to climb if it’s not going to have a 2011/2-esque year and a desperate willingness to suggest anything. Read more »

Gotta do what I gotta do.John Paulson has a problem: He took a huge bath when AbbVie decided not to buy Shire because, even though it was ready to pay $54 billion for the company, the Irish pharma was basically just a tax shelter to Shire, and of the sort that is no longer kosher in the precincts of the U.S. Treasury Department. Now, John Paulson is Shire’s third-largest shareholder, and 30% drops in a company in which one is the third-largest shareholder are the kind of thing likely to produce something approaching panic in a hedge-fund manager.

John Paulson also owns a lot of Allergan shares. You may have heard of Allergan, either because it makes Botox, or because Bill Ackman talks about it a lot.

John Paulson has been listening closely to what Bill Ackman says about Allergan, which is that the company should take Valeant Pharmaceuticals $53 billion (or more?) offer and that if it doesn’t, he’s going to throw out its entire board and make Allergan take the deal. And John Paulson likes that plan. He likes it a lot. But he’d like it even more if all of those Shire shares he owns would one day be worth as much as they were when he bought them, all of those months ago, when tax inversions were the order of the day. And he has an idea on that front… Read more »

John Paulson Doesn’t Want To Run A Mutual Fund, But…

John Paulson’s strategies are pretty complex, if he may say so himself, as he does. So if he had his druthers, he’d stick with making money (and occasionally losing money) for investors as savvy and sophisticated as he is.

The only problem is, some of those savvy and sophisticated investors are getting a little uppity about little things like $2.3 billion paychecks and 2/20 for sub-S&P500 returns and the like. Well, hear this: If institutional investors don’t want to pay John Paulson, John Paulson will find someone else who does. Read more »

John Paulson is sticking to his story that he won’t be moving to the tax-friendly shores of the Singapore of the Caribbean. On the other hand, he’s just bought some pretty nice Class A space from Robert Benmosche to go along with all of those miles of beachfront on which he could conceivably live. Read more »

John Paulson Had A Pretty Good May

Mostly due to a killer Memorial Day weekend BBQ out east, but he’ll take what he can get. Read more »